Search This Blog

Wednesday, November 6, 2019

Albireo Pharma EPS misses by $0.17, beats on revenue

Albireo Pharma (NASDAQ:ALBO): Q3 GAAP EPS of -$1.73 misses by $0.17.
Revenue of $1.39M (+479.2% Y/Y) beats by $0.43M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)